Rachel Ludwig

Rachel Ludwig represents a wide range of clients in the healthcare and life sciences industry on various regulatory, compliance, and transactional matters. She is a member of the firm's Healthcare Industry team in the Washington, DC office.

Rachel advises healthcare clients on regulatory, compliance, and transactional matters, including strategic structuring and governance issues, digital health regulatory matters, structuring and implementing telehealth networks, fraud and abuse analysis, investigations, self-disclosures, and repayments, health information privacy and security considerations, as well as billing and reimbursement, and licensing and accreditation guidance for healthcare providers and suppliers. Her broad healthcare regulatory expertise is valued by clients, particularly when embarking on significant strategic corporate reorganizations and internal restructurings. Rachel regularly represents healthcare providers with complex corporate footprints through sophisticated structural realignment to enhance regulatory compliance and foster future goals. She also routinely guides clients through strategic healthcare transactions and provides counseling on regulatory requirements and risks related to mergers and acquisitions and private equity investment, including strategic structuring of transactions, navigating the evolving state regulatory landscape with respect to state transaction review laws and corporate practice of medicine restrictions, evaluating and managing risk related to complex fraud and abuse fact patterns, and obtaining all required regulatory approvals from state and federal agencies. Rachel has previously served as an independent reviewer for entities under Corporate Integrity Agreements and also has experience representing providers in certificate of need proceedings.